M. Amaya

Phase I study of pexidartinib (PLX3397) in children with refractory leukemias and solid tumors including neurofibromatosis type I (NF1) related plexiform neurofibromas (PN).

R. Kaplan, B. Widemann, J. Glod, 2017 .